Learn more

GLYKOS FINLAND OY

Overview
  • Total Patents
    188
  • GoodIP Patent Rank
    24,489
  • Filing trend
    ⇧ 166.0%
About

GLYKOS FINLAND OY has a total of 188 patent applications. It increased the IP activity by 166.0%. Its first patent ever was published in 2002. It filed its patents most often in Finland, United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are THE BRIGHAM AND WOMENS HOSPITAL, ACADEMIA SINICA and SINOBIOWAY BIOMEDICINE CO LTD.

Patent filings per year

Chart showing GLYKOS FINLAND OYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Natunen Jari 124
#2 Saarinen Juhani 96
#3 Satomaa Tero 95
#4 Helin Jari 80
#5 Heiskanen Annamari 55
#6 Hiltunen Jukka 40
#7 Olonen Anne 34
#8 Saloheimo Markku 32
#9 Blomqvist Maria 30
#10 Huuskonen Anne 27

Latest patents

Publication Filing date Title
CN111065416A Hydrophilic linkers and conjugates thereof
EP3334751A1 Regulatory protein deficient trichoderma cells and methods of use thereof
SG11201700446XA Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
CA2954934A1 Saccharide derivative of a toxic payload and antibody conjugates thereof
WO2015197919A1 Antibody drug conjugates binding to high-mannose n-glycan
US2017189549A1 Payload-Polymer-Protein Conjugates
EP2991683A1 Conjugates of a glycoprotein or a glycan with a toxic payload
US2016068818A1 A method for generating induced pluripotent stem cells
WO2014096551A1 Linker-payload molecule conjugates
WO2014053709A1 A method for culturing stem cells
GB201303405D0 Chelator Molecule
WO2013087992A1 Glycoprotein
US2015191544A1 Glycoprotein
FI20115511A0 Isoform chips and related methods for antibodies
FI20110160A0 Methods of production of substitution
FI20105737A0 Production of sugar-containing compositions by the hydrolysis of cells
EP2315828A2 Method for culturing induced pluripotent stem cells with a lectin
FI20090144A0 New substance and methods
FI20080665A0 Natural saccharide compositions
EP2296688A2 Peptide vaccine for influenza virus